Camelot Care (Somerset) Limited 06381355 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is the operation of a nursing home Digita Accounts Production Advanced 6.30.9574.0 true true true true false 06381355 2024-01-01 2024-12-31 06381355 2024-12-31 06381355 bus:OrdinaryShareClass1 2024-12-31 06381355 core:AcceleratedTaxDepreciationDeferredTax 2024-12-31 06381355 core:RevaluationPropertyDeferredTax 2024-12-31 06381355 core:RetainedEarningsAccumulatedLosses 2024-12-31 06381355 core:RevaluationReserve 2024-12-31 06381355 core:ShareCapital 2024-12-31 06381355 core:CurrentFinancialInstruments 2024-12-31 06381355 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 06381355 core:Non-currentFinancialInstruments 2024-12-31 06381355 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 06381355 core:BetweenOneFiveYears 2024-12-31 06381355 core:BetweenTwoFiveYears 2024-12-31 06381355 core:WithinOneYear 2024-12-31 06381355 core:ConstructionInProgressAssetsUnderConstruction 2024-12-31 06381355 core:FurnitureFittingsToolsEquipment 2024-12-31 06381355 core:LandBuildings 2024-12-31 06381355 core:MotorVehicles 2024-12-31 06381355 core:OtherPropertyPlantEquipment 2024-12-31 06381355 core:DeferredTaxation 2024-12-31 06381355 bus:FRS102 2024-01-01 2024-12-31 06381355 bus:Audited 2024-01-01 2024-12-31 06381355 bus:FullAccounts 2024-01-01 2024-12-31 06381355 bus:RegisteredOffice 2024-01-01 2024-12-31 06381355 bus:CompanySecretaryDirector1 2024-01-01 2024-12-31 06381355 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 06381355 bus:Consolidated 2024-01-01 2024-12-31 06381355 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 06381355 bus:Agent1 2024-01-01 2024-12-31 06381355 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 06381355 core:RevaluationReserve 2024-01-01 2024-12-31 06381355 core:ShareCapital 2024-01-01 2024-12-31 06381355 core:Buildings 2024-01-01 2024-12-31 06381355 core:ComputerEquipment 2024-01-01 2024-12-31 06381355 core:ConstructionInProgressAssetsUnderConstruction 2024-01-01 2024-12-31 06381355 core:FurnitureFittings 2024-01-01 2024-12-31 06381355 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31 06381355 core:LandBuildings 2024-01-01 2024-12-31 06381355 core:MotorCars 2024-01-01 2024-12-31 06381355 core:MotorVehicles 2024-01-01 2024-12-31 06381355 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 06381355 core:DeferredTaxation 2024-01-01 2024-12-31 06381355 core:KeyManagementPersonnel 2024-01-01 2024-12-31 06381355 core:OtherRelatedParties 2024-01-01 2024-12-31 06381355 core:ParentEntities 2024-01-01 2024-12-31 06381355 core:UKTax 2024-01-01 2024-12-31 06381355 1 2024-01-01 2024-12-31 06381355 countries:EnglandWales 2024-01-01 2024-12-31 06381355 2023-12-31 06381355 core:RetainedEarningsAccumulatedLosses 2023-12-31 06381355 core:RevaluationReserve 2023-12-31 06381355 core:ShareCapital 2023-12-31 06381355 core:ConstructionInProgressAssetsUnderConstruction 2023-12-31 06381355 core:FurnitureFittingsToolsEquipment 2023-12-31 06381355 core:LandBuildings 2023-12-31 06381355 core:MotorVehicles 2023-12-31 06381355 core:OtherPropertyPlantEquipment 2023-12-31 06381355 core:DeferredTaxation 2023-12-31 06381355 2023-01-01 2023-12-31 06381355 2023-12-31 06381355 bus:OrdinaryShareClass1 2023-12-31 06381355 core:AcceleratedTaxDepreciationDeferredTax 2023-12-31 06381355 core:RevaluationPropertyDeferredTax 2023-12-31 06381355 core:RetainedEarningsAccumulatedLosses 2023-12-31 06381355 core:RevaluationReserve 2023-12-31 06381355 core:ShareCapital 2023-12-31 06381355 core:CurrentFinancialInstruments 2023-12-31 06381355 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 06381355 core:Non-currentFinancialInstruments 2023-12-31 06381355 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 06381355 core:BetweenOneFiveYears 2023-12-31 06381355 core:BetweenTwoFiveYears 2023-12-31 06381355 core:WithinOneYear 2023-12-31 06381355 core:ConstructionInProgressAssetsUnderConstruction 2023-12-31 06381355 core:FurnitureFittingsToolsEquipment 2023-12-31 06381355 core:LandBuildings 2023-12-31 06381355 core:MotorVehicles 2023-12-31 06381355 core:OtherPropertyPlantEquipment 2023-12-31 06381355 core:UKTax 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company Registration number: 06381355

Camelot Care (Somerset) Limited

Annual Report and Financial Statements

for the Year Ended 31 December 2024

 

Camelot Care (Somerset) Limited

Contents

Company Information

1

Strategic Report

2 to 3

Director's Report

4

Statement of Director's Responsibilities

5

Independent Auditor's Report

6 to 9

Profit and Loss Account

10

Statement of Comprehensive Income

11

Balance Sheet

12

Statement of Changes in Equity

13

Notes to the Financial Statements

14 to 27

 

Camelot Care (Somerset) Limited

Company Information

Director

P I Teasdale

Company secretary

P I Teasdale

Registered office

Suite 106 C/O Walpole Dunn
Viney Court
Viney Street
Taunton
Somerset
TA1 3FB

Auditors

Albert Goodman LLP 5th Floor
25 King Street
Bristol
BS1 4PB

 

Camelot Care (Somerset) Limited

Strategic Report for the Year Ended 31 December 2024

The director presents his strategic report for the year ended 31 December 2024.

Principal activity

The principal activity of the company is the operation of a nursing home.

Fair review of the business

Turnover of £6,174,062 (2023: £5,961,575) was converted into a profit for the year, after taxation, of £1,302,414 (2023: £1,285,674).

The company has continued strong trading performance despite the increase in the National Living Wage and continued high administrative and establishment costs.

The company recognises the importance of its workforce and continues to prioritise staffing and recruitment.

The management of costs whilst ensuring appropriate weekly rates and high levels of occupancy has been key to ensuring strong trading performance throughout the year.

The director is confident that the approach of reinvesting profits in the company will mean that the home is well placed to consolidate its position in the region as a key strategic partner for the local authority as well as attracting self-funders to its homes through its reputation for delivering high-quality care.

Our key aim above all is to provide outstanding care to our service users in a safe and welcoming environment for residents, their families, and employees.

The home specialises in providing care to people who have dementia and other mental health needs. To help ensure the excellence of our service we monitor and focus on:

1. The provision of high-quality care and support, measured by internal assessments and external confirmation, including the Care Quality Commission (CQC) inspections and reports.

2. Recruitment and retention of quality staff, measured in terms of customer feedback, staff turnover and our success and investment in training our employees with an aim of enhancing the number of staff holding nationally accredited qualifications in care.

3. Maintenance of high levels of occupancy.

Principal risks and uncertainties

The principal risks and uncertainties of the company are:

1. CQC regulation: the health, safety and other regulatory requirements as outlined by the CQC. The group strives to mitigate these risks by providing excellent care to its residents and ensuring its care procedures are continually monitored and updated through regular quality assessment.

2. Interest rate and compliance with banking covenants risk: The group has financed its operations through a mix of short- and medium-term borrowings and available cash balances. The director monitors the interest rate risk and ongoing covenants compliance.

 

Camelot Care (Somerset) Limited

Strategic Report for the Year Ended 31 December 2024

Approved by the Board on 2 September 2025 and signed on its behalf by:


P I Teasdale
Company secretary and director

   
 

Camelot Care (Somerset) Limited

Director's Report for the Year Ended 31 December 2024

The director presents his report and the financial statements for the year ended 31 December 2024.

Director of the company

The director who held office during the year was as follows:

P I Teasdale - Company secretary and director

Financial instruments

Objectives and policies

The company's principal financial instruments comprise bank balances, bank loans, trade creditors, trade debtors and group receivables and payables. The main purpose of these instruments is to manage funds to finance the company's operations.

Price risk, credit risk, liquidity risk and cash flow risk

Due to the nature of the financial instruments used by the company there is no exposure to price risk. The company's approach to managing other risks applicable to the financial instruments concerned is shown below.

In respect of bank balances, the liquidity risk is managed by maintaining a balance between the continuity of funding and loans from financial institutions. The interest rate on the loans from financial institutions is variable but the monthly repayments are fixed.

The company manages the liquidity risk by ensuring there are sufficient funds to meet the payments.

Trade debtors are managed in respect of credit and cash flow risk by policies concerning the credit offered to customers and the regular monitoring of amounts outstanding for both time and credit limits.

Trade creditors liquidity risk is managed by ensuring sufficient funds are available to meet amounts due.

Future Developments

The future developments of the business are included within the strategic report.

Disclosure of information to the auditors

The director has taken steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information. The director confirms that there is no relevant information that he knows of and of which he knows the auditors are unaware.

Approved by the Board on 2 September 2025 and signed on its behalf by:


P I Teasdale
Company secretary and director

   
 

Camelot Care (Somerset) Limited

Statement of Director's Responsibilities

The director acknowledges his responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Camelot Care (Somerset) Limited

Independent Auditor's Report to the Members of Camelot Care (Somerset) Limited

Opinion

We have audited the financial statements of Camelot Care (Somerset) Limited (the 'company') for the year ended 31 December 2024, which comprise the Profit and Loss Account, Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its profit for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

 

Camelot Care (Somerset) Limited

Independent Auditor's Report to the Members of Camelot Care (Somerset) Limited

Other information

The director is responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Director's Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Director's Report have been prepared in accordance with applicable legal requirements.

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Director's Report.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of director's remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of the director

As explained more fully in the Statement of Director's Responsibilities set out on page 5, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or have no realistic alternative but to do so.

 

Camelot Care (Somerset) Limited

Independent Auditor's Report to the Members of Camelot Care (Somerset) Limited

Auditor Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

The extent to which the audit was considered capable of detecting irregularities including fraud

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;

we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the sector;

we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006, taxation legislation, employment, environmental and health, safety legislation and the CQC requirements;

we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence; and

identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and

considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

To address the risk of fraud through management bias and override of controls, we:

performed analytical procedures to identify any unusual or unexpected relationships;

tested journal entries to identify unusual transactions;

assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias; and

investigated the rationale behind significant or unusual transactions.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

 

Camelot Care (Somerset) Limited

Independent Auditor's Report to the Members of Camelot Care (Somerset) Limited

agreeing financial statement disclosures to underlying supporting documentation;

enquiring of management as to actual and potential litigation and claims; and

reviewing correspondence with HMRC and relevant regulators.

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.





Neil Johnston (Senior Statutory Auditor)
For and on behalf of Albert Goodman LLP, Statutory Auditor

5th Floor
25 King Street
Bristol
BS1 4PB

3 September 2025

 

Camelot Care (Somerset) Limited

Profit and Loss Account
for the Year Ended 31 December 2024

Note

2024
 £

2023
 £

Turnover

3

6,174,062

5,961,575

Cost of sales

 

(4,028,006)

(3,830,427)

Gross profit

 

2,146,056

2,131,148

Administrative expenses

 

(583,518)

(637,587)

Other operating income

4

67,549

84,489

Operating profit

5

1,630,087

1,578,050

Reversal of depreciation on revaluation

 

145,004

130,259

Interest payable and similar charges

6

(69,019)

(66,751)

Profit before tax

 

1,706,072

1,641,558

Taxation

10

(403,658)

(355,884)

Profit for the financial year

 

1,302,414

1,285,674

The above results were derived from continuing operations.

 

Camelot Care (Somerset) Limited

Statement of Comprehensive Income
for the Year Ended 31 December 2024

2024
£

2023
£

Profit for the year

1,302,414

1,285,674

Surplus on property, plant and equipment revaluation

2,523,622

737,221

Deferred tax relating to other comprehensive income

(585,879)

(50,523)

1,937,743

686,698

Total comprehensive income for the year

3,240,157

1,972,372

 

Camelot Care (Somerset) Limited

(Registration number: 06381355)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

11

10,600,000

7,994,415

Current assets

 

Debtors

12

4,751,183

3,731,897

Cash at bank and in hand

 

208,201

101,254

 

4,959,384

3,833,151

Creditors: Amounts falling due within one year

14

(655,474)

(697,135)

Net current assets

 

4,303,910

3,136,016

Total assets less current liabilities

 

14,903,910

11,130,431

Creditors: Amounts falling due after more than one year

14

(760,075)

(812,632)

Provisions for liabilities

15

(1,382,603)

(796,724)

Net assets

 

12,761,232

9,521,075

Capital and reserves

 

Called up share capital

100

100

Revaluation reserve

4,639,481

2,701,738

Retained earnings

8,121,651

6,819,237

Shareholders' funds

 

12,761,232

9,521,075

Approved and authorised by the director on 2 September 2025
 


P I Teasdale
Company secretary and director

   
 

Camelot Care (Somerset) Limited

Statement of Changes in Equity
for the Year Ended 31 December 2024

Ordinary share capital
£

Revaluation reserve
£

Profit and loss reserve
£

Total
£

At 1 January 2024

100

2,701,738

6,819,237

9,521,075

Profit for the year

-

-

1,302,414

1,302,414

Gain on revaluation of property

-

-

2,523,622

2,523,622

Deferred tax relating to other comprehensive income

-

-

(585,879)

(585,879)

Total comprehensive income

-

-

3,240,157

3,240,157

Revaluation of freehold property

-

2,523,622

(2,523,622)

-

Transfer of deferred tax on fair value adjustments

-

(585,879)

585,879

-

At 31 December 2024

100

4,639,481

8,121,651

12,761,232

Ordinary share capital
£

Revaluation reserve
£

Profit and loss reserve
£

Total
£

At 1 January 2023

100

2,015,040

5,533,563

7,548,703

Movement in year :

Profit for the year

-

-

1,285,674

1,285,674

Gain on revaluation of property

-

-

737,221

737,221

Deferred tax relating to other comprehensive income

-

-

(50,523)

(50,523)

Total comprehensive income

-

-

1,972,372

1,972,372

Revaluation of freehold property

-

737,221

(737,221)

-

Transfer of deferred tax on fair value adjustments

-

(50,523)

50,523

-

Total movement for the year

-

686,698

1,285,674

1,972,372

At 31 December 2023

100

2,701,738

6,819,237

9,521,075

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Suite 106 C/O Walpole Dunn
Viney Court
Viney Street
Taunton
Somerset
TA1 3FB

The principal place of business is:
Camelot House Nursing Home
Taunton Road
Chelston
Wellington
Somerset
TA21 9HY

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

These financial statements are presented in Sterling (£).

Summary of disclosure exemptions

The company has taken advantage of the exemption from preparing a statement of cash flows, net debt reconciliation and from all other requirements of Section 11, Basic Financial Instruments and Section 12, Other Financial Instruments Issues, as the company is a member of a group that prepares publicly available consolidated financial statements.

The company has taken advantage of the exemption in FRS102 1.12(c) from disclosing transactions with the wholly owned members of the group.

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

Going concern

The director has made the assessment that the company is a going concern and these financial statements are prepared on that basis. The assessment took into account the forecasts and projections to assess that the company has adequate resources to continue in operational existence for the foreseeable future.

Judgements

The preparation of the financial statements requires management to make judgments, estimates and assumptions that affect the amounts reported for assets and liabilities as at the statement of financial position date and the amounts reported for revenues and expenses during the year. However the nature of estimation means that actual outcomes could differ from those estimates. The following judgements have had the most significant effect on amounts recognised in the financial statements.

Valuation of properties
The Company carries its freehold property at fair value, with changes in fair value being recognised in other comprehensive income. The Company engaged independent valuation specialists to determine fair value at 7 October 2024. The valuer used the profits method of valuation as they consider the market norm is to assess this type of asset for sale purposes by reference to its trading characteristics and profitability. The Director having made appropriate enquiries has adopted a similar model to arrive at the current year-end valuation.

Turnover recognition

Revenue represents the fair value of consideration receivable, excluding Value Added Tax, in the ordinary course of business for services provided.

Revenue from residents of the care homes is recognised and apportioned on the basis of usage, and accrued or deferred as appropriate.

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.

Grants of a revenue nature are recognised in the statement of comprehensive income in the same period as the related expenditure.

Other operating income

Other operating income is recognised on receipt.

Tax

The tax expense for the period comprises current tax. Tax is recognised in the profit and loss account, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

Deferred tax is recognised on timing differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Deferred tax liabilities are presented within provisions for liabilities on the balance sheet.

Tangible assets

Tangible assets are stated at cost, less accumulated depreciation and accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Freehold property

- 2% on cost, Land - nil

Fixtures and fittings

- 25% reducing balance

Motor vehicles

- 25% reducing balance

Computer equipment

- 25% reducing balance

Revaluation of tangible fixed assets

Individual freehold and leasehold properties are carried at fair value at the date of the revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Revaluations are undertaken with sufficient regularity to ensure the carrying amount does not differ materially from that which would be determined using fair value at the reporting date.

Fair values are determined from market based evidence normally undertaken by professionally qualified valuers.

Revaluation gains and losses are recognised in other comprehensive income unless losses exceed the previously recognised gains or reflect a clear consumption of economic benefits, in which case the excess losses are recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Assets held under hire purchase agreements are capitalised as tangible fixed assets with the future obligation being recognised as a liability. Finance costs are recognised in the Profit and Loss Account calculated at a constant periodic rate of interest over the term of the liability.

Reserves

Called up share capital represents the nominal value of shares that have been issued.

Profit and loss account includes all current and prior period profits and losses.

Revaluation reserve is the surplus or deficit arising on the revaluation of an asset of a company.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

Defined contribution pension obligation

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations.

The contributions are recognised as an expense in the profit and loss account when they fall due. Amounts not paid are shown in accruals as a liability in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Financial instruments

Classification
The company only holds basic financial instruments as defined in FRS 102. The financial assets and financial liabilities of the company are as follows:

Financial assets – trade and other debtors, accrued income, amounts owed by group undertakings
and other debtors are basic financial instruments, and are debt instruments measured at amortised
cost. Prepayments are not financial instruments.

Cash at bank – is classified as a basic financial instrument and is measured at face value.

Financial liabilities – trade creditors, amounts owed to group undertakings, bank loans, accrued expenses and other creditors are financial instruments, and are measured at amortised cost. Taxation and social security and corporation tax creditors are not included in the financial instruments disclosure definition.

 

3

Turnover

The analysis of the company's turnover for the year from continuing operations is as follows:

2024
£

2023
£

Rendering of services

6,174,062

5,961,575

4

Other operating income

The analysis of the company's other operating income for the year is as follows:

2024
£

2023
£

Other operating income

67,549

84,489

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

5

Operating profit

Arrived at after charging/(crediting)

2024
£

2023
£

Depreciation expense

187,867

185,772

6

Interest payable and similar expenses

2024
£

2023
£

Interest expense on other finance liabilities

69,019

66,751

7

Staff costs

The aggregate payroll costs (including director's remuneration) were as follows:

2024
£

2023
£

Wages and salaries

2,864,147

2,344,777

Social security costs

281,503

222,852

Pension costs, defined contribution scheme

45,303

38,418

Other employee expense

22,104

43,201

3,213,057

2,649,248

The average number of persons employed by the company (including the director) during the year, analysed by category was as follows:

2024
No.

2023
No.

Administration and support

104

94

104

94

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

8

Director's remuneration

The director's remuneration for the year was as follows:

2024
£

2023
£

Remuneration

22,291

71,063

Contributions paid to money purchase schemes

383

6,137

22,674

77,200

During the year the number of directors who were receiving benefits and share incentives was as follows:

2024
No.

2023
No.

Accruing benefits under defined benefit pension scheme

1

1

9

Auditors' remuneration

2024
£

2023
£

Audit of the financial statements

7,400

7,050


 

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

10

Taxation

Tax charged/(credited) in the profit and loss account

2024
£

2023
£

Current taxation

UK corporation tax

403,658

355,884

The tax on profit before tax for the year is the same as the standard rate of corporation tax in the UK (2023 - the same as the standard rate of corporation tax in the UK) of 25% (2023 - 23.5%).

The differences are reconciled below:

2024
£

2023
£

Profit before tax

1,706,072

1,641,558

Corporation tax at standard rate

426,518

385,766

Tax decrease from effect of capital allowances and depreciation

-

(23,081)

Tax increase from other short-term timing differences

-

13,956

Tax decrease arising from group relief

(23,432)

(20,287)

Other tax effects for reconciliation between accounting profit and tax expense (income)

572

(470)

Total tax charge

403,658

355,884

From 1 April 2023, the Corporation Tax main rate for non-ring fenced profits will be increased to 25% applying to profits over £250,000. Companies with profits of £50,000 or less will continue to pay Corporation Tax at 19%. Companies with profits between £50,000 and £250,000 will pay tax at the main rate reduced by a marginal relief providing a gradual increase in the effective Corporation Tax rate.

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

11

Tangible assets

Freehold property
£

Fixtures, fittings and equipment
 £

Motor vehicles
 £

Properties under construction
 £

Computer equipment
 £

Total
£

Cost or valuation

At 1 January 2024

7,750,175

692,555

25,044

66,415

30,488

8,564,677

Revaluations

2,523,622

-

-

-

-

2,523,622

Additions

-

21,268

-

97,960

5,598

124,826

Disposals

-

-

(1,100)

-

-

(1,100)

At 31 December 2024

10,273,797

713,823

23,944

164,375

36,086

11,212,025

Depreciation

At 1 January 2024

-

532,806

18,757

-

18,699

570,262

Charge for the year

145,004

37,386

1,570

-

3,907

187,867

Eliminated on disposal

-

-

(1,100)

-

-

(1,100)

Eliminated on revaluation

(145,004)

-

-

-

-

(145,004)

At 31 December 2024

-

570,192

19,227

-

22,606

612,025

Carrying amount

At 31 December 2024

10,273,797

143,631

4,717

164,375

13,480

10,600,000

At 31 December 2023

7,750,175

159,749

6,287

66,415

11,789

7,994,415

Included within the net book value of land and buildings above is £10,273,797 (2023 - £7,750,175) in respect of freehold land and buildings.
 

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

Cost or valuation at 31 December 2024 is represented by:
 

Freehold property

Fixture fittings & equipment

Motor vehicles

Computer equipment

Properties under construction

Totals

£

£

£

£

£

£

Valuation in 2024

2,523,622

Valuation in 2023

737,221

737,221

Valuation in 2022

946,530

946,530

Valuation in 2020

(133,759)

-

-

-

-

(133,759)

Valuation in 2018

(234,000)

-

-

-

-

(234,000)

Valuation in 2014

1,578,734

-

-

-

-

1,578,734

Cost

4,855,449

713,823

23,944

36,086

164,375

5,793,877

10,273,797

713,823

23,944

36,086

164,375

11,212,025

If freehold land and buildings had not been revalued they would have been included at the following historical cost:

 

2024

2023

£

£

Cost

4,855,449

4,855,449

Aggregate depreciation

717,871

620,762

Value of land in freehold land and buildings

500,000

500,000

The property was revalued at £10,600,000 in October 2024 by T Harrison MRICS and A Burchell MRICS of Avision Young, professional valuers.

The Director having made appropriate enquiries has adopted a similar model to arrive at the current year-end valuation.

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

12

Debtors

Note

2024
£

2023
£

Trade debtors

 

330,685

276,361

Amounts owed by group undertakings

20

4,380,630

3,423,284

Other debtors

 

6,462

7,014

Prepayments

 

31,490

25,238

Accrued income

 

1,916

-

 

4,751,183

3,731,897

13

Cash and cash equivalents

2024
£

2023
£

Cash on hand

169

23

Cash at bank

208,032

101,231

208,201

101,254

14

Creditors

Note

2024
 £

2023
 £

Due within one year

 

Loans and borrowings

16

52,984

45,909

Trade creditors

 

81,873

126,277

Social security and other taxes

 

65,243

67,364

Other creditors

 

12,899

14,384

Accrued expenses

 

235,260

190,681

Corporation tax

10

207,215

252,520

 

655,474

697,135

Due after one year

 

Loans and borrowings

16

760,075

812,632

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

15

Provisions for liabilities

Deferred tax
£

Total
£

At 1 January 2024

796,724

796,724

Increase (decrease) in existing provisions

585,879

585,879

At 31 December 2024

1,382,603

1,382,603

Deferred tax

Deferred tax assets and liabilities:

2024

Asset
£

Liability
£

Accelerated tax depreciation

4,383

-

Revaluation of property

-

1,386,986

4,383

1,386,986

2023

Asset
£

Liability
£

Accelerated tax depreciation

-

34,039

Revaluation of property

-

762,685

-

796,724

16

Loans and borrowings

Current loans and borrowings

2024
£

2023
£

Bank borrowings

52,984

45,909

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

760,075

812,632

Included in bank and borrowings is a bank loan which is denominated in sterling with a nominal interest rate of 3% above the Bank of England base rate, repayable in monthly instalments to 26 March 2026. The carrying amount at the year end is £823,059 (2023 - £858,541).

The bank borrowings are secured on a fixed and floating charge across all assets including cross guarantees within the Camelot Care Group and a personal guarantee from the Director.

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

17

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary of £1 each

100

100

100

100

         

18

Obligations under leases and hire purchase contracts

Operating leases

The total of future minimum lease payments is as follows:

2024
£

2023
£

Not later than one year

36,101

27,062

Later than one year and not later than five years

58,944

-

95,045

27,062

The amount of non-cancellable operating lease payments recognised as an expense during the year was £40,538 (2023 - £44,000).

Operating leases - lessor

The total of future minimum lease payments is as follows:

2024
£

2023
£

Not later than one year

14,000

6,667

Later than one year and not later than five years

65,333

-

79,333

6,667

Total rents recognised as income in the period are £10,033 (2023 - £8,000).

19

Pension and other schemes

Defined contribution pension scheme

The company operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the company to the scheme and amounted to £45,303 (2023 - £38,418).

 

Camelot Care (Somerset) Limited

Notes to the Financial Statements
for the Year Ended 31 December 2024

20

Related party transactions

Key management personnel

The director is the only individual classified as key management personnel. See Directors remuneration note 8.

Summary of transactions with key management

Summary of transactions with parent

The company has taken advantage of not disclosing transactions with its parent company on the grounds it is a wholly owned subsidiary.

Summary of transactions with other related parties

Able Angels Limited ("Able Angels")
 A company owned by Mrs HJ Teasdale and family.

During the year the company was supplied with services from Able Angels amounting to £626,056 (2023: £924,465). At the year end the amount owed to Able Angels was £14,234 (2023: £94,707).

 
Park Asset Management Limited
A company owned by Mr S Teasdale, a shareholder of the parent company.

During the year the company was supplied with services from Park Asset Management Ltd amounting to £22,858 (2023: £24,162). At the year end the amount owed to/by Park Asset Management Ltd was £nil (2023: £nil).

Bavent Asset Management Limited
A company owned by Mr P Teasdale, a director of the parent company.

During the year the company was supplied with services from Bavent Asset Management Ltd amounting to £17,680 (2023: £17,680) and provided services amounting to £140 (2023: £nil). At the year end the amount owed to/by Bavent Asset Management Ltd was £nil (2023: £nil).
 

21

Parent and ultimate parent undertaking

The company's immediate parent is Camelot Care Limited, incorporated in England and Wales.

 The ultimate controlling party is Mr P I Teasdale.